Instituto Nacional de Investigación en Salud Pública
- World rank, 2022–2025
- #22,537 of 28,054 · #37,252 all time
- Rank in Ecuador
- #58 of 71
- Research works
- 303 ▲ 127% vs 2013–17
- Citations
- 2.2k 7.4 per fractional work
- Top-10% rate
- 15.2% record average 16.5%
- Open access
- 63% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 5.7×. Every wedge is a field page.
- Veterinary 5.7×
- Dentistry 4.8×
- Immunology and Microbiology 4.7×
- Medicine 1.9×
- Economics, Econometrics and Finance 1.7×
- Agricultural and Biological Sciences 1.6×
- Environmental Science 1.4×
- Neuroscience 1.4×
- Energy 1.4×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Nursing 1.1×
- Health Professions 1.1×
- Business, Management and Accounting 1.0×
- Arts and Humanities 0.9×
- Social Sciences 0.6×
- Earth and Planetary Sciences 0.6×
- Mathematics 0.5×
- Psychology 0.5×
- Computer Science 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Decision Sciences 0.3×
- Chemistry 0.1×
- Engineering 0.1×
- Materials Science 0.1×
Which keywords describe research at Instituto Nacional de Investigación en Salud Pública?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine Development, Public Health, SARS-CoV-2, Immune Response, Diagnosis, Vaccine and Pandemic.
- spike protein
- Viral Transmission
- Competitiveness
- Chronic Disease Control
- Coronavirus
- Immunity
- Arboviral Diseases
- Psychopharmacology Education
- Innovation Ecosystems
- Digital Marketing
- Urban Development
- Sustainable Development
- Economic Impact
- Vector Control
- Pathogenesis
- Vaccine
- SARS-CoV-2
- Diagnosis
- Climate Change
- Public Health
- Epidemiology
- Vaccine Development
- Pandemic
- COVID-19
- Immune Response
- Education
- Treatment
- Drug Resistance
- Small and Medium Enterprises
- Biodiversity
- ACE2 Receptor
- Genetic Diversity
- Antibiotic Resistance
- Tourism Management
- Zika Virus
- Invasive Species
- Healthcare Access
- Community-based Resource Management
- Genome Sequence
- antibody
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology18▲ 5.8×50 topics
- Public Health5▲ 4.7×17 topics
- Vaccine Development5▲ 26×8 topics
- Climate Change5▲ 2.4×19 topics
- Pandemic4▲ 5.4×8 topics
- Diagnosis4▲ 6.0×14 topics
- COVID-194▲ 4.0×12 topics
- SARS-CoV-24▲ 16×4 topics
- Immune Response4▲ 8.9×12 topics
- Vaccine4▲ 12×7 topics
- Education4▲ 2.7×13 topics
- Pathogenesis4▲ 9.0×14 topics
- Treatment3▲ 3.7×12 topics
- Vector Control3▲ 38×4 topics
- Drug Resistance3▲ 15×6 topics
- Economic Impact3▲ 6.9×2 topics
- Small and Medium Enterprises3▲ 22×2 topics
- Sustainable Development3▲ 2.4×7 topics
- Biodiversity3▲ 4.7×9 topics
- Urban Development3▲ 9.5×4 topics
- ACE2 Receptor3▲ 14×2 topics
- Digital Marketing2▲ 7.7×2 topics
- Genetic Diversity2▲ 7.3×6 topics
- Innovation Ecosystems2▲ 32×2 topics
- Antibiotic Resistance2▲ 8.3×6 topics
- Psychopharmacology Education2▲ 47×1 topic
- Tourism Management2▲ 42×1 topic
- Arboviral Diseases2▲ 44×1 topic
- Zika Virus2▲ 44×1 topic
- Immunity2▲ 6.5×3 topics
- Invasive Species2▲ 6.1×7 topics
- Coronavirus2▲ 11×2 topics
- Healthcare Access2▲ 7.7×2 topics
- Chronic Disease Control2▲ 113×1 topic
- Community-based Resource Management2▲ 113×1 topic
- Competitiveness2▲ 27×3 topics
- Genome Sequence2▲ 26×2 topics
- Viral Transmission2▲ 14×3 topics
- antibody2▲ 18×1 topic
- spike protein2▲ 18×1 topic
Which research topics does Instituto Nacional de Investigación en Salud Pública publish most on?
By volume in 2022–2025: Business, Innovation, and Economy, Mosquito-borne diseases and control, Public Health and Environmental Issues and SARS-CoV-2 and COVID-19 Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Business, Innovation, and Economy Economics and Econometrics 2 works
- 2 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 2 works
- 3 Public Health and Environmental Issues Health, Toxicology and Mutagenesis 2 works
- 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 5 SARS-CoV-2 detection and testing Infectious Diseases 1 works
- 6 Pain Management and Placebo Effect Cognitive Neuroscience 1 works
- 7 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 8 Malaria Research and Control Public Health, Environmental and Occupational Health 1 works
- 9 Tuberculosis Research and Epidemiology Infectious Diseases 1 works
- 10 Dental Anxiety and Anesthesia Techniques Oral Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto Nacional de Investigación en Salud Pública's research output changed?
Output in 2018–2022 was 127% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Guayaquil
- University of Guayaquil
- Universidad Estatal de Milagro
- Escuela Superior Politecnica del Litoral
- Universidad Católica de Santiago de Guayaquil
- Universidad Espíritu Santo
- Universidad Metropolitana
- Universidad Ecotec
- Universidad Agraria del Ecuador
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.